GGrantIndex
← Leaderboards

Stephen D. Ginsberg

Nathan S. Kline Institute For Psych Res

$17,729,760
Attributed
$28,088,537
Total exposure
14
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.8M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,088,537 · 14

By mechanism

R01$16,679,890 · 5
P01$5,947,472 · 4
RF1$2,466,001 · 1
R56$1,757,526 · 2
P50$1,049,073 · 1
R21$188,575 · 1

Top collaborators

Most similar at Nathan S. Kline Institute For Psych Res

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposNeuronsCellsFunctional DisorderBrainS DiseaseMolecularPathway InteractionsGenesPathologicNerve DegenerationDesignCell TypeLinkEventSiteAutopsyHippocampus (Brain)Impaired CognitionGene ExpressionPathologyProteinsInnovationInvestigation

Grant awards (48)

Neuropathology and inflammation in a nonhuman primate model of insulin resistance/metabolic syndrome$1,250,276
R01 · FY2025 · AG
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum$1,151,816
R01 · FY2025 · AG
Selective interactome vulnerability across the Alzheimer’s disease spectrum$1,047,941
R01 · FY2025 · AG
Neuropathology and inflammation in a nonhuman primate model of insulin resistance/metabolic syndrome$1,306,289
R01 · FY2024 · AG
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum$1,182,309
R01 · FY2024 · AG
Selective interactome vulnerability across the Alzheimer’s disease spectrum$1,076,035
R01 · FY2024 · AG
Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimer’s disease pathophysiology$2,466,001
RF1 · FY2023 · AG · contact PI
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum$1,189,094
R01 · FY2023 · AG
Selective interactome vulnerability across the Alzheimer’s disease spectrum$1,165,481
R01 · FY2023 · AG
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum$1,195,676
R01 · FY2022 · AG
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum$1,240,570
R01 · FY2021 · AG
Selective interactome vulnerability across the Alzheimer’s disease spectrum$1,162,517
R56 · FY2021 · AG
Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function$350,418
P01 · FY2021 · AG · contact PI
Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function$350,418
P01 · FY2020 · AG · contact PI
Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function$350,418
P01 · FY2019 · AG · contact PI
Pathogenic consequences of altered insulin signaling in the diabetic brain.$595,009
R56 · FY2018 · AG
Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function$350,418
P01 · FY2018 · AG · contact PI
Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjects$758,376
R01 · FY2017 · AG
Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function$350,418
P01 · FY2017 · AG · contact PI
Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjects$758,376
R01 · FY2016 · AG
Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjects$735,625
R01 · FY2015 · AG
EXPRESSION PROLIFING OF ENDOSOMAL PATHWAYS IN AD$297,529
P01 · FY2015 · AG · contact PI
Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjects$666,738
R01 · FY2014 · AG
EXPRESSION PROLIFING OF ENDOSOMAL PATHWAYS IN AD$306,732
P01 · FY2014 · AG · contact PI
Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjects$672,940
R01 · FY2013 · AG
EXPRESSION PROLIFING OF ENDOSOMAL PATHWAYS IN AD$289,861
P01 · FY2013 · AG · contact PI
Neuronal basis of sensory processing dysfunction in schizophrenia$203,043
P50 · FY2013 · MH · contact PI
EXPRESSION PROLIFING OF ENDOSOMAL PATHWAYS IN AD$306,732
P01 · FY2012 · AG · contact PI
Neuronal basis of sensory processing dysfunction in schizophrenia$219,690
P50 · FY2012 · MH · contact PI
Neuronal basis of sensory processing dysfunction in schizophrenia$211,141
P50 · FY2011 · MH · contact PI
Neuronal basis of sensory processing dysfunction in schizophrenia$208,274
P50 · FY2010 · MH · contact PI
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD$369,889
P01 · FY2009 · AG · contact PI
Neuronal basis of sensory processing dysfunction in schizophrenia$206,925
P50 · FY2009 · MH · contact PI
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD$333,362
P01 · FY2008 · AG · contact PI
Single Cell Gene Expression Profiling in hTau Mice$198,283
P01 · FY2008 · NS · contact PI
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD$333,994
P01 · FY2007 · AG · contact PI
Single Cell Gene Expression Profiling in hTau Mice$233,873
P01 · FY2007 · NS · contact PI
Single Cell Gene Expression Profiling in hTau Mice$311,853
P01 · FY2006 · NS · contact PI
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD$294,577
P01 · FY2006 · AG · contact PI
Single Cell Gene Expression Profiling in hTau Mice$292,031
P01 · FY2006 · NS · contact PI
Single Cell Gene Expression Profiling in hTau Mice$340,669
P01 · FY2005 · NS
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD$285,997
P01 · FY2005 · AG
Lesion Induced Synaptic Plasticity$334,391
R01 · FY2004 · NS
Lesion Induced Synaptic Plasticity$333,786
R01 · FY2003 · NS
Molecular Diagnosis Utilizing Cerebrospinal Fluid$94,666
R21 · FY2003 · CA
Lesion Induced Synaptic Plasticity$329,741
R01 · FY2002 · NS
Molecular Diagnosis Utilizing Cerebrospinal Fluid$93,909
R21 · FY2002 · CA
Lesion Induced Synaptic Plasticity$284,430
R01 · FY2001 · NS